XML 24 R14.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 6 - Goodwill and Intangible Assets, Net | 9 Months Ended
--- | ---
Dec. 31, 2023
Notes to Financial Statements |
Goodwill and Intangible Assets Disclosure [Text Block] | Note 6. Goodwill and Intangible Assets, Net Intangible assets, the significant majority of which are finite-lived, consisted of the following:
|  | December 31, 2023 |  |  | March 31, 2023 |
|  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Net Carrying Amount |  |  | Gross Carrying Amount |  |  | Accumulated Amortization |  |  | Net Carrying Amount |
Customer relationships |  | $ | 265,408 |  |  | $ | (102,518 | ) |  | $ | 162,890 |  |  | $ | 238,247 |  |  | $ | (86,058 | ) |  | $ | 152,189 |
Intellectual property |  |  | 71,169 |  |  |  | (25,416 | ) |  |  | 45,753 |  |  |  | 65,950 |  |  |  | (19,550 | ) |  |  | 46,400 |
Other intangibles |  |  | 31,867 |  |  |  | (7,736 | ) |  |  | 24,131 |  |  |  | 24,793 |  |  |  | (6,567 | ) |  |  | 18,226 |
Total |  | $ | 368,444 |  |  | $ | (135,670 | ) |  | $ | 232,774 |  |  | $ | 328,990 |  |  | $ | (112,175 | ) |  | $ | 216,815 |
Amortization expense for finite-lived intangible assets acquired in a business combination was as follows:
|  | Three Months Ended December 31, |  |  | Nine Months Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2023 |  |  | 2022 |
Amortization in cost of revenues |  | $ | 1,883 |  |  | $ | 1,695 |  |  | $ | 5,367 |  |  | $ | 5,094 |
Amortization in general and administrative |  |  | 6,092 |  |  |  | 5,452 |  |  |  | 17,013 |  |  |  | 16,479 |
Total |  | $ | 7,975 |  |  | $ | 7,147 |  |  | $ | 22,380 |  |  | $ | 21,573 |
For the following fiscal years ending March 31, amortization expense is estimated as follows:
Remainder of 2024 |  | $ | 8,389 |
2025 |  |  | 32,663 |
2026 |  |  | 31,857 |
2027 |  |  | 31,200 |
2028 |  |  | 30,587 |
The change in the carrying amount of goodwill was as follows:
|  | Sterilization and Disinfection Control |  |  | Clinical Genomics |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
March 31, 2023 |  | $ | 29,559 |  |  | $ | 135,811 |  |  | $ | 83,857 |  |  | $ | 37,217 |  |  |  | 286,444 |
Effect of foreign currency translation |  |  | 2,460 |  |  |  | (55 | ) |  |  | 2,009 |  |  |  | 14 |  |  |  | 4,428 |
Goodwill related to GKE acquisition |  |  | 54,470 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 54,470 |
Measurement period adjustment, Belyntic Acquisition |  |  | - |  |  |  | - |  |  |  | 841 |  |  |  | - |  |  |  | 841 |
December 31, 2023 |  | $ | 86,489 |  |  | $ | 135,756 |  |  | $ | 86,707 |  |  | $ | 37,231 |  |  | $ | 346,183 |
Goodwill in the Biopharmaceutical Development division related to the Belyntic acquisition and goodwill in the Sterilization and Disinfection Control division related to the GKE acquisition are expected to be tax deductible.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration